Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis. 2007

Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

We report that osteopenia is a prominent and previously unappreciated clinical feature of patients with X-linked hyper-IgM syndrome, an inherited immune deficiency disorder caused by mutations in the gene encoding CD40 ligand (CD40L). We therefore conducted studies to determine the relationship between CD40L and osteoclastogenesis. Recognizing that activated T cells express surface receptor activator of NF-kappaB ligand (RANKL) and can induce osteoclast differentiation of myeloid cells expressing RANK, we assessed the capacity of wild-type T cells and CD40L(-/-) T cells to induce osteoclastogenesis in vitro. Relative to wild-type T cells, activated CD40L(-/-) T cells from both humans and mice promoted robust osteoclast differentiation of myeloid cells. Whereas activated CD40L(-/-) T cells had normal expression of RANKL, they were deficient in IFN-gamma production. In subsequent studies, we cultured activated CD40L(-/-) T cells in the presence of IFN-gamma, and we found that the osteoclastic capacity of CD40L(-/-) T cells could be greatly diminished. These results show that CD40L can influence RANKL signaling through T cell priming, and thus they demonstrate a regulatory role for CD40L in bone mineralization that is absent in patients with X-linked hyper-IgM syndrome.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010010 Osteoclasts A large multinuclear cell associated with the BONE RESORPTION. An odontoclast, also called cementoclast, is cytomorphologically the same as an osteoclast and is involved in CEMENTUM resorption. Odontoclasts,Cementoclast,Cementoclasts,Odontoclast,Osteoclast
D010012 Osteogenesis The process of bone formation. Histogenesis of bone including ossification. Bone Formation,Ossification, Physiologic,Endochondral Ossification,Ossification,Ossification, Physiological,Osteoclastogenesis,Physiologic Ossification,Endochondral Ossifications,Ossification, Endochondral,Ossifications,Ossifications, Endochondral,Osteoclastogeneses,Physiological Ossification
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
November 1993, Immunology today,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
February 1993, Science (New York, N.Y.),
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
April 1999, The Journal of biological chemistry,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
February 1993, Nature,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
October 2011, Blood,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
May 2021, Molecular genetics & genomic medicine,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
January 1996, Human mutation,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
October 1998, Blood,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
May 1997, Human genetics,
Eduardo Lopez-Granados, and Stephane T Temmerman, and Lynne Wu, and James C Reynolds, and Dean Follmann, and Shuying Liu, and David L Nelson, and Frank Rauch, and Ashish Jain
July 2023, bioRxiv : the preprint server for biology,
Copied contents to your clipboard!